文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

前列腺癌挽救性放疗后DCE-MRI评估局部病灶反应模式的前瞻性研究

A prospective study assessing the pattern of response of local disease at DCE-MRI after salvage radiotherapy for prostate cancer.
PubMed 文献 · Clin Transl Radiat Oncol · 2022-04-27

这项单中心前瞻性研究纳入62例根治性前列腺切除术后DCE-MRI发现局部失败的患者,共72个结节,接受挽救性放疗(前列腺窝66-69 Gy、局部病灶73.5 Gy,30次)。首次复查时53.2%患者达完全缓解,中位达CR时间4.7个月;病灶体积和放疗后时间是首次复查CR的独立预测因素。

要点

  • 挽救性放疗后多数局部病灶可完全消失,但需数月时间,中位达CR时间为4.7个月。
  • 首次复查时33例(53.2%)患者达完全缓解。
  • 放疗前DCE-MRI病灶体积是首次复查CR的独立预测因素(OR 0.076)。

核心结论

  • 本研究记录到剂量递增挽救性放疗后绝大多数局部病灶完全消失,但这需要放疗后数月时间。
  • 完全缓解的时间至少部分可根据病灶体积预测。

研究设计与样本

  • 单中心前瞻性研究,于2017年8月至2020年6月入组根治性前列腺切除术后DCE-MRI发现一处或多处局部失败的患者。
  • 患者接受单纯挽救性放疗:前列腺窝66-69 Gy,DCE-MRI所见局部失败灶73.5 Gy,均为30次。
  • 放疗后每3个月行DCE-MRI复查,直至病灶完全消失或最多复查4次。
  • 共入组62例患者、72个结节。

主要发现

  • 所有患者均完成第1次复查,33例(53.2%)显示完全缓解。
  • 中位达完全缓解时间为4.7个月。
  • 4例患者在达到完全缓解前未再进行复查,即使将这些患者视为无反应,绝大多数病灶(87.1%,95%CI:78.5-94.4%)在挽救性放疗结束后12个月内已完全消失。
  • 放疗前DCE-MRI病灶体积是第1次复查时完全缓解的独立预测因素(OR:0.076,95%CI:0.009-0.667;p=0.020)。
  • 放疗后时间也是第1次复查时完全缓解的独立预测因素(OR:3.399,95%CI:1.156-9.993,p=0.026)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To assess the pattern of response of presumed local lesions at dynamic contrast enhancement magnetic resonance imaging (DCE-MRI) after salvage radiotherapy (sRT). METHODS: This is a prospective study conducted at a single Institution accruing patients with one or more local failures at DCE-MRI after radical prostatectomy between August 2017 and June 2020. Patients underwent exclusive sRT delivering 66-69 Gy and 73.5 Gy in 30 fractions to the whole prostatic fossa and to the local failure(s) seen at DCE-MRI, respectively.Patients were offered DCE-MRI at 3 months intervals after sRT until complete disappearance (CR) of the lesion(s) or up to a maximum of 4 revaluations. RESULTS: 62 patients with 72 nodules were enrolled. All patients underwent the 1st revaluation, and 33 patients (53.2%) showed a CR. The median time to CR was 4.7 months. Four patients did not undergo further testing before achieving a CR and even considering these patients as no responses, the vast majority (87.1%, 95%CI: 78.5-94.4%) of lesions would have completely disappeared by 12 months from the end of sRT.The volume of the lesion at pre-sRT DCE-MRI was an independent predictor of CR at the 1st revaluation (OR: 0.076, 95%CI: 0.009-0.667; p = 0.020) along with time elapsed from sRT (OR: 3.399, 95% CI: 1.156-9.993, p = 0.026). CONCLUSIONS: The present study documents the complete disappearance of the vast majority of local lesions after dose-escalated sRT though this requires several months after sRT; timing of CR is at least in part predictable based on the volume of the lesion.Trial registration: Clinicaltrials.gov NCT04703543, registered July 15 2020, retrospectively registered, https://clinicaltrials.gov/ct2/show/NCT04703543.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Bottero M, Faiella A, Giannarelli D, et al. A prospective study assessing the pattern of response of local disease at DCE-MRI after salvage radiotherapy for prostate cancer. Clin Transl Radiat Oncol. 2022. PMID: 35516461. doi:10.1016/j.ctro.2022.04.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。